Study ID: TVP-1012/PM103

Study Title

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Teva Identifier

TVP-1012/PM103

ClinicalTrials.gov Identifier

NCT01049984

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

12/01/2009 - 10/01/2012

Phase

Phase 4

Study Type

Interventional